| TTM
|
3/31/2026
|
3/31/2025
|
3/31/2024
|
3/31/2023
|
|
|---|---|---|---|---|---|
| Total Revenue
|
40,269,000 | 40,182,000 | 38,843,000 | 38,538,000 | 38,075,000 |
| Cost of Revenue
|
-32,105,000 | -32,182,000 | -30,089,000 | -31,222,000 | -31,764,000 |
|
Gross Profit
|
8,163,000 | 8,000,000 | 8,753,000 | 7,316,000 | 6,311,000 |
|
Operating Income/Expenses
|
-5,693,000 | -5,584,000 | -5,410,000 | -5,052,000 | -5,019,000 |
|
Total Operating Profit/Loss
|
2,470,000 | 2,416,000 | 3,343,000 | 2,264,000 | 1,292,000 |
| Total Net Finance Income/Expense
|
-51,000 | -21,000 | 21,000 | 35,000 | 52,000 |
| Net Investment Income
|
1,053,000 | 1,032,000 | 498,000 | 350,000 | 78,000 |
| Irregular Income/Expenses
|
-238,000 | 180,000 | -462,000 | -477,000 | -189,000 |
|
Other Income/Expense, Non-Operating
|
81,000 | 30,000 | -98,000 | 56,000 | 52,000 |
|
Non-Operating Income/Expenses, Total
|
845,000 | 1,221,000 | -41,000 | -36,000 | -7,000 |
|
Pretax Income
|
3,315,000 | 3,634,000 | 3,299,000 | 2,225,000 | 1,286,000 |
| Provision for Income Tax
|
-719,000 | -740,000 | -739,000 | -634,000 | -430,000 |
|
Net Income from Continuing Operations
|
2,596,000 | 2,894,000 | 2,560,000 | 1,591,000 | 856,000 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
2,594,000 | 2,894,000 | 2,559,000 | 1,590,000 | 855,000 |
|
Net Income after Non-Controlling/Minority Interests
|
2,594,000 | 2,894,000 | 2,559,000 | 1,590,000 | 855,000 |
|
Net Income Available to Common Stockholders
|
2,594,000 | 2,894,000 | 2,559,000 | 1,590,000 | 855,000 |
|
Diluted Net Income Available to Common Stockholders
|
2,594,000 | 2,894,000 | 2,559,000 | 1,590,000 | 855,000 |
| Basic EPS
|
297.78 | 331.39 | 290.62 | 180.35 | 97.13 |
| Diluted EPS
|
297.18 | 330.82 | 289.98 | 180.31 | 97.10 |
|
Basic Weighted Average Shares Outstanding
|
8,719.26 | 8,734 | 8,806 | 8,816.19 | 8,802.64 |
|
Diluted Weighted Average Shares Outstanding
|
8,733.26 | 8,748 | 8,824.81 | 8,818.10 | 8,805.56 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
3,366,000 | 3,655,000 | 3,278,000 | 2,190,000 | 1,234,000 |
|
EBITDA
|
7,395,000 | 7,395,000 | 6,860,000 | 5,873,000 | 4,565,000 |
|
Normalized EBITDA
|
6,188,000 | 6,188,000 | 6,841,000 | 6,063,000 | 4,722,000 |
|
Normalized Income
|
2,473,000 | 2,375,000 | 3,199,000 | 2,383,000 | 1,412,000 |
|
Total Unusual Items
|
354,000 | -1,207,000 | -19,000 | 190,000 | 157,000 |
|
Total Unusual Items Excluding Goodwill
|
354,000 | -1,207,000 | -19,000 | 190,000 | 157,000 |
|
Tax Effect of Unusual Items
|
76,780.12 | -246,228 | -4,256 | 54,150 | 52,595 |
|
Tax Rate, Calculated
|
0.22 | 0.20 | 0.22 | 0.28 | 0.34 |
3/31/2023 - 1/1/2001
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade